Oncologists visit pharma sites most often, survey says

Share this article:

Oncologists visit product sites and post content online more frequently than the average US physician, a Manhattan Research survey found.

According to the survey, nearly 70% of oncologists in the US visit corporate pharmaceutical, biotech and device websites at least monthly, and are three-times as likely to contribute online health-related content.

“The insight that oncologists are ‘above average' in the digital realm is no surprise to the enlightened brand manager with an eye towards the future – a future in which reps are simply part of the promotional mix and not the center of it,” said Mark Bard, president of Manhattan Research, in a statement. “The findings also highlight the need to further refine a professional strategy based on the needs of individual physician specialist segments. Clearly, companies can't use a one-size-fits-all approach when addressing a physician audience online.”


Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.